Handling and Staging of Renal Cell Carcinoma: The International Society of Urological Pathology Consensus (ISUP) Conference Recommendations

The International Society of Urologic Pathology 2012 Consensus Conference on renal cancer, through working group 3, focused on the issues of staging and specimen handling of renal tumors. The conference was preceded by an online survey of the International Society of Urologic Pathology members, and the results of this were used to inform the focus of conference discussion. On formal voting a ≥65% majority was considered a consensus agreement. For specimen handling it was agreed that with radical nephrectomy specimens the initial cut should be made along the long axis and that both radical and partial nephrectomy specimens should be inked. It was recommended that sampling of renal tumors should follow a general guideline of sampling 1 block/cm with a minimum of 3 blocks (subject to modification as needed in individual cases). When measuring a renal tumor, the length of a renal vein/caval thrombus should not be part of the measurement of the main tumor mass. In cases with multiple tumors, sampling should include at a minimum the 5 largest tumors. There was a consensus that perinephric fat invasion should be determined by examining multiple perpendicular sections of the tumor/perinephric fat interface and by sampling areas suspicious for invasion. Perinephric fat invasion was defined as either the tumor touching the fat or extending as irregular tongues into the perinephric tissue, with or without desmoplasia. It was agreed upon that renal sinus invasion is present when the tumor is in direct contact with the sinus fat or the loose connective tissue of the sinus, clearly beyond the renal parenchyma, or if there is involvement of any endothelium-lined spaces within the renal sinus, regardless of the size. When invasion of the renal sinus is uncertain, it was recommended that at least 3 blocks of the tumor-renal sinus interface should be submitted. If invasion is grossly evident, or obviously not present (small peripheral tumor), it was agreed that only 1 block was needed to confirm the gross impression. Other recommendations were that the renal vein margin be considered positive only when there is adherent tumor visible microscopically at the actual margin. When a specimen is submitted separately as “caval thrombus,” the recommended sampling strategy is to take 2 or more sections to look for the adherent caval wall tissue. It was also recommended that uninvolved renal parenchyma be sampled by including normal parenchyma with tumor and normal parenchyma distant from the tumor. There was consensus that radical nephrectomy specimens should be examined for the purpose of identifying lymph nodes by dissection/palpation of the fat in the hilar area only; however, it was acknowledged that lymph nodes are found in <10% of radical nephrectomy specimens.

[1]  Lars Egevad,et al.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia , 2013, The American journal of surgical pathology.

[2]  B. Delahunt,et al.  International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. , 2013, The American journal of surgical pathology.

[3]  B. Delahunt,et al.  Renal Tumors: Diagnostic and Prognostic Biomarkers , 2013, The American journal of surgical pathology.

[4]  J. Cheville,et al.  The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters , 2013, The American journal of surgical pathology.

[5]  J. Milner,et al.  Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat. , 2013, Archives of pathology & laboratory medicine.

[6]  B. Shuch,et al.  The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors. , 2012, The Urologic clinics of North America.

[7]  Liang Cheng,et al.  Lymphadenectomy in urologic oncology: pathologic considerations. , 2011, The Urologic clinics of North America.

[8]  C. Compton,et al.  TNM seventh edition: What's new, what's changed , 2010, Cancer.

[9]  C. de Bazelaire,et al.  Hereditary renal cancer syndromes: an update of a systematic review. , 2010, European urology.

[10]  F. Montorsi,et al.  Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? , 2010, European urology.

[11]  B. Delahunt,et al.  Renal Cell Neoplasms of Oncocytosis Have Distinct Morphologic, Immunohistochemical, and Cytogenetic Profiles , 2010, The American journal of surgical pathology.

[12]  D. de Jong,et al.  Hereditary causes of kidney tumours , 2010, European journal of clinical investigation.

[13]  J. Cheville,et al.  Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. , 2010, The Journal of urology.

[14]  A. Renshaw,et al.  Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin. , 2010, Archives of pathology & laboratory medicine.

[15]  B. Delahunt Advances and controversies in grading and staging of renal cell carcinoma , 2009, Modern Pathology.

[16]  J. Brooks,et al.  Recommendations for the reporting of surgically resected specimens of renal cell carcinoma: the Association of Directors of Anatomic and Surgical Pathology. , 2009, Human pathology.

[17]  C. Lohse,et al.  Multifocal Renal Cell Carcinoma: Clinicopathologic Features and Outcomes for Tumors ≤4 cm , 2008, Advances in urology.

[18]  S. Bonsib Macroscopic assessment, dissection protocols and histologic sampling strategy for renal cell carcinomas , 2008 .

[19]  A. Villers,et al.  Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance. , 2008, The Journal of urology.

[20]  J. Cheville,et al.  Patients With pT1 Renal Cell Carcinoma Who Die From Disease After Nephrectomy May Have Unrecognized Renal Sinus Fat Invasion , 2007, The American journal of surgical pathology.

[21]  F. Algaba,et al.  What does the urologist expect from the pathologist (and what can the pathologists give) in reporting on adult kidney tumour specimens? , 2007, European urology.

[22]  J. Patard,et al.  Multi-institutional validation of a new renal cancer-specific survival nomogram. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Grignon,et al.  Renal Cell Carcinoma and the Renal Sinus , 2007, Advances in anatomic pathology.

[24]  S. Bonsib Renal lymphatics, and lymphatic involvement in sinus vein invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases , 2006, Modern Pathology.

[25]  H. Moch,et al.  Spectrum of Epithelial Neoplasms in End-Stage Renal Disease: An Experience From 66 Tumor-Bearing Kidneys With Emphasis on Histologic Patterns Distinct From Those in Sporadic Adult Renal Neoplasia , 2006, The American journal of surgical pathology.

[26]  J. Cheville,et al.  Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? , 2005, The Journal of urology.

[27]  S. Bonsib T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. , 2005, The Journal of urology.

[28]  F. Guillé,et al.  Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma , 2005, Cancer.

[29]  F. Marshall The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. , 2005, The Journal of urology.

[30]  D. Grignon,et al.  Handling and reporting of tumor-containing kidney specimens. , 2005, Clinics in laboratory medicine.

[31]  J. Cheville,et al.  Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma. , 2005, The Journal of urology.

[32]  J. Cheville,et al.  Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a? , 2005, The Journal of urology.

[33]  S. Fleming,et al.  Best Practice No 180 Nephrectomy for renal tumour; dissection guide and dataset , 2004, Journal of Clinical Pathology.

[34]  J. Cheville,et al.  Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. , 2004, Urology.

[35]  F. Algaba,et al.  Handling and pathology reporting of renal tumor specimens. , 2004, European urology.

[36]  M. Kattan,et al.  Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. , 2004, The Journal of urology.

[37]  V. Ficarra,et al.  Tumor-size breakpoint for prognostic stratification of localized renal cell carcinoma. , 2004, Urology.

[38]  J. Cheville,et al.  Solid renal tumors: an analysis of pathological features related to tumor size. , 2003, The Journal of urology.

[39]  A. Sagalowsky,et al.  Reassessment of the 1997 TNM classification system for renal cell carcinoma , 2003, Cancer.

[40]  J. Srigley,et al.  Protocol for the examination of specimens from patients with Wilms tumor (nephroblastoma) or other renal tumors of childhood. , 2003, Archives of pathology & laboratory medicine.

[41]  D. Griffiths,et al.  Evaluation of a protocol for examining nephrectomy specimens with renal cell carcinoma , 2003, Journal of clinical pathology.

[42]  J. Cheville,et al.  Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.

[43]  R. Figlin,et al.  TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. , 2003, The Journal of urology.

[44]  E. Castelli,et al.  The number of lymph nodes examined and staging accuracy in renal cell carcinoma , 2003, BJU international.

[45]  R. Figlin,et al.  Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  Matthew P. Rutman,et al.  Clinical and pathologic tumor size in renal cell carcinoma; difference, correlation, and analysis of the influencing factors. , 2002, Urology.

[47]  B. Delahunt,et al.  Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma , 2002, Cancer.

[48]  M. Kattan,et al.  A postoperative prognostic nomogram for renal cell carcinoma. , 2001, The Journal of urology.

[49]  R. Figlin,et al.  Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome. , 2001, The Journal of urology.

[50]  H. Ito,et al.  The impact of a 4 cm. cutoff point for stratification of T1N0M0 renal cell carcinoma after radical nephrectomy. , 2001, The Journal of urology.

[51]  H. Moch,et al.  Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma , 2000, Cancer.

[52]  D. Govender The pathology of nephroblastoma , 2000 .

[53]  S. Bonsib,et al.  Renal sinus involvement in renal cell carcinomas. , 2000, The American journal of surgical pathology.

[54]  M. Rubin,et al.  Renal oncocytosis: a morphologic study of fourteen cases. , 1999, The American journal of surgical pathology.

[55]  C. Zuppan Handling and evaluation of pediatric renal tumors. , 1998, American journal of clinical pathology.

[56]  J. Eble Recommendations for examining and reporting tumor-bearing kidney specimens from adults. , 1998, Seminars in diagnostic pathology.

[57]  J. Beckwith,et al.  National Wilms Tumor Study: An Update for Pathologists , 1998, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[58]  A. Pathology,et al.  Recommendations for the reporting of resected neoplasms of the kidney , 1996, Virchows Archiv.

[59]  J. Cheville,et al.  Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. , 2011, European urology.

[60]  D. Jacqmin,et al.  Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. , 2009, European urology.

[61]  B. Ljungberg Radical Nephrectomy with and without Lymph-Node Dissection: Final Results of European Organization for Research and Treatment of Cancer (EORTC) Randomized Phase 3 Trial 30881 , 2009 .

[62]  S. Bonsib Renal veins and venous extension in clear cell renal cell carcinoma , 2007, Modern Pathology.

[63]  M. Kattan,et al.  A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. , 2005, The Journal of urology.

[64]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.